Table 1.
Case | Bacteremia no. | Patient age (yr) | Sourcea | TEE performeda,b | Treatment length (days)a | Days to relapse | Days of bacteremia/outcome | MIC (μg/ml)d |
||
---|---|---|---|---|---|---|---|---|---|---|
Vanc | Dapto | Linezolid | ||||||||
1 | 1 | 62 | Unknown | Yes | 14 | 8 | 1.5 | 0.5 | 1.5 | |
2 | 14 | 1/death | 1.5 | 0.5 | 0.75 | |||||
2 | 1 | 64 | Skin | Yesc | 17 | 16 | 0.75 | 0.75 | 1 | |
2 | 16 | 6/death | 0.5 | 0.5 | 0.5 | |||||
3 | 1 | 51 | Unknown | Yes | 13 | 1 | 1.5 | 0.38 | 0.38 | |
2 | 102 | 15 | 2 | 0.5 | 0.38 | |||||
4 | 1 | 58 | Catheter | Yes | 28 | 14 | 2 | 0.75 | 0.5 | |
2 | 20 | 22/death | 3 | 1 | 0.75 | |||||
5 | 1 | 62 | Skin | No | 17 | 5 | 1.5 | 0.19 | 1 | |
2 | 120 | 6 | 3 | 1 | 0.75 | |||||
6 | 1 | 67 | Unknown | Yes | 30 | 19 | 1.5 | 0.38 | 0.75 | |
2 | 14 | 10 | 1.5 | 0.25 | 0.75 | |||||
7 | 1 | 20 | Unknown | Yes | 14 | 1 | 1.5 | 0.38 | 0.75 | |
2 | 36 | 3 | 1.5 | 0.25 | 0.5 | |||||
8 | 1 | 27 | Respiratory | Yes | 14 | 10 | 1.5 | 0.38 | 1 | |
2 | 23 | 20 | 1.5 | 0.38 | 0.75 | |||||
9 | 1 | 32 | Unknown | Yes | 18 | 4 | 1.5 | 0.38 | 0.75 | |
2 | 41 | 5 | 1.5 | 0.25 | 0.5 | |||||
10 | 1 | 18 | Unknown | No | 19 | 2 | 1.5 | 0.25 | 0.75 | |
2 | 45 | 5 | 1.5 | 0.38 | 0.75 | |||||
3 | 35 | 4 | 2 | 0.38 | 0.75 | |||||
11 | 1 | 66 | Multiple sites | Yes | 22 | 14 | 1.5 | 0.38 | 0.75 | |
2 | 79 | 16/death | 1.5 | 0.5 | 2 |
Refers to the initial bacteremic episode.
TEE, transesophageal echocardiogram.
Endocarditis was diagnosed on the second episode of bacteremia for case 2. No other cases of endocarditis were detected.
Vanc, vancomycin; Dapto, daptomycin.